Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne
NCT04582383 · View on ClinicalTrials.gov ↗
Study Summary
Acne is common illness of adolescents and young adults which is associated with substantial morbidity. While topical treatments are often sufficient for mild acne, moderate to severe acne often requires treatment with systemic medications such as oral antibiotics, hormonal therapies such spironolactone, and isotretinoin. Sebum overproduction is fundamental to the pathogenesis of acne with associated disordered keratinization and subsequent microbial colonization and inflammation resulting in the clinical manifestations of acne. Given the influence of hormones on sebum production, therapies that address these underlying hormonal factors such as spironolactone and oral contraceptive pills represent an underutilized treatment option for women with acne and could help decrease the use of long-term oral antibiotics in this patient population. The purpose of this trial is to evaluate the comparative effectiveness of spironolactone versus doxycycline hyclate (tetracycline class antibiotic) for women with acne.
Conditions Studied
Interventions
- DRUG Spironolactone
- DRUG Doxycycline Hyclate
Study Locations (18)
Texas
- Arlington Research Center — Arlington
- North Texas Center for Clinical Research — Frisco
- CCS Texas — Houston
California
- University of California San Francisco — San Francisco
- Cura Clinical Research — Sherman Oaks
Florida
- University of Miami — Miami
- New Horizon Research Center — Miami
New York
- New York University — New York
- Northwell Health — North New Hyde Park
Ohio
- Dermatologists of Central States — Cincinnati
- Ohio State University Medical Center — Columbus
Oregon
- Cyn3rgy Research — Gresham
- Oregon Health and Science University — Portland
Pennsylvania
- Children's Hospital of Philadelphia — Philadelphia
- University of Pennsylvania — Philadelphia
Arkansas
- Johnson Dermatology — Fort Smith
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2022-03-30 |
| Est. Completion | 2026-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04582383
The ClinicalTrials.gov registry entry for NCT04582383 describes a study currently listed as active not recruiting. It is categorized as Phase 4, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,457 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Acne appearing as the primary indexed condition, and to 2 interventions — of which Spironolactone is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT04582383 reports 18 study locations spanning 10 distinct geographic areas — top geographies include Texas, California, Florida. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT04582383 about?
NCT04582383 is a clinical study titled "Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne". Acne is common illness of adolescents and young adults which is associated with substantial morbidity. While topical treatments are often sufficient for mild acne, moderate to severe acne often requires treatment with systemic medications such as oral antibiotics, hormonal therapies such spironolact...
What is the current status of trial NCT04582383?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 350 participants. The study started on 2022-03-30. Estimated completion is 2026-07-31.
What conditions does trial NCT04582383 study?
This clinical trial studies the following conditions: Acne. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT04582383?
The interventions under investigation include: Spironolactone (DRUG), Doxycycline Hyclate (DRUG). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT04582383?
This trial is sponsored by University of Pennsylvania, which has 1,457 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT04582383 being conducted?
This trial has 18 study locations across Arkansas, California, Florida, Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.